Home UAE Abu Dhabi UAE’s Burjeel, US-based Northwell Health to launch neuroscience institute in UAE The neuroscience institute will be located at Burjeel Medical City in Abu Dhabi by Gulf Business June 9, 2023 Image: Burjeel Holdings Burjeel Holdings (Burjeel) has joined hands with Northwell Health, the largest healthcare provider in New York State, to launch a highly advanced neuroscience institute in Abu Dhabi. The Neuroscience Institute will be located at Burjeel Medical City, and will provide advanced care for adult and pediatric patients with neurological disorders, including autoimmune brain disorders, epilepsy, Parkinson’s and movement disorders, pediatric neurology, and multiple sclerosis. Neurologist Dr Souhel Najjar, professor and chairperson, Department of Neurology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, and executive director and SVP of the Northwell Health Neurology Service Line, will head the institute in Abu Dhabi. Dr Souhel Najjar commented that the decision to build a neuroscience institute in the UAE demonstrated the entities’ synergistic culture of innovation and commitment to bring advanced, innovative, and compassionate neurological care to the UAE and the entire Middle East. “On a personal level, I am proud of this relationship as it allows me to bring my Northwell Health family closer to the beloved UAE.” Burjeel Holdings-Northwell Health sign agreement in Manhattan Burjeel Holdings and Northwell Health formalised the establishment of the ‘Dr. Najjar Neuroscience Institute’ at a ceremony held in New York at the Northwell Health corporate headquarters in Manhattan. Michael J Dowling, president and CEO, Northwell Health, said: “This collaboration is an exciting opportunity to deliver world-class care to the communities of Abu Dhabi. “Dr Najjar has long been an example of clinical excellence for our health system and we are incredibly proud to see his team’s services offered across the globe.” John Sunil, CEO, Burjeel Holdings, added: “The partnership is another important step in the Burjeel Holdings’ commitment to delivering unmatched healthcare excellence in the region and greatly improving patient outcomes. The collaboration with Northwell Health and Dr Najjar aligns with the group’s endeavours to provide complex care and access to the newest treatments and technologies for patients across the region.” In recent news, the company reported a 43.4 per cent increase in first-quarter net profit to $33m (Dhs121.3m), driven by higher revenues, increased operational efficiencies and lower finance costs linked to ongoing debt reduction. The healthcare services provider said its revenues surged by 11.6 per cent year-on-year (YoY) to Dhs1.1bn in the first quarter of 2023, thanks to the improved performance of Burjeel Medical City (BMC) and the medical centres’ segments. Tags Burjeel Holdings Dr. Najjar Neuroscience Institute Healthcare Northwell Health UAE. US 0 Comments You might also like PureHealth’s IPO attracts Dhs265bn in orders UAE’s Purehealth seeks to raise Dhs3.62bn from IPO Saudi Arabia’s Avalon Pharma sets eyes on global expansion Abu Dhabi-based PureHealth announces intention to list on ADX